Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms - PubMed (original) (raw)
Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms
W H Kutteh et al. Am J Obstet Gynecol. 1992 Dec.
Abstract
Objective: Our objective was to determine the presence and quantities of multifunctional cytokines in cyst and ascites fluids obtained from patients with ovarian cancer.
Study design: Cyst and ascites fluids obtained from 35 patients with ovarian epithelial neoplasms were analyzed for the multifunctional cytokines tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. The fluids were classified on the basis of the pathologic diagnosis of the tumor tissue. Data were evaluated by analysis of variance.
Results: The fluids from patients with papillary forms of adenocarcinoma had high levels of all three cytokines when compared with all other pathologic groups. Interleukin-6 was significantly higher than tumor necrosis factor-alpha or interleukin-1 beta in fluids from all diagnostic categories (p < 0.01). Interleukin-6 levels were significantly higher in fluids from patients with papillary serous cystadenocarcinoma (817 +/- 137 pg/ml) and papillary adenocarcinoma (838 +/- 171 pg/ml) (p < 0.01). Interleukin-1 beta was significantly elevated (p < 0.01) in neoplastic effusions from papillary serous cystadenocarcinomas (53 +/- 8 pg/ml), mucinous cystadenomas (51 +/- 12 pg/ml), and endometrioid carcinomas (54 +/- 18 pg/ml). Tumor necrosis factor-alpha was highest in fluids from patients with papillary adenocarcinoma (46.2 +/- 22.8 pg/ml); however, these levels were not significantly different from the mean quantities of tumor necrosis factor-alpha in other fluids.
Conclusions: The detection of interleukin-1 beta and interleukin-6 in neoplastic effusions provides possible evidence for a host immune response to ovarian cancer. These multifunctional cytokines have been implicated in growth stimulation and cytotoxicity of ovarian tumor cells.
Similar articles
- Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramakrishnan S. Moradi MM, et al. Cancer. 1993 Oct 15;72(8):2433-40. doi: 10.1002/1097-0142(19931015)72:8<2433::aid-cncr2820720822>3.0.co;2-l. Cancer. 1993. PMID: 8402460 - Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.
Kutteh WH, Gall SA, Doellgast GJ, Allitto BA, Dawson JR. Kutteh WH, et al. Am J Obstet Gynecol. 1984 Sep 1;150(1):65-9. doi: 10.1016/s0002-9378(84)80111-8. Am J Obstet Gynecol. 1984. PMID: 6476028 - Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S, Amberger A, Pollheimer J, Gastl G, Offner FA, Margreiter R, Zeimet AG. Stadlmann S, et al. Gynecol Oncol. 2005 Jun;97(3):784-9. doi: 10.1016/j.ygyno.2005.02.017. Gynecol Oncol. 2005. PMID: 15943987 - Stroke therapy. It may be time for an integrated approach.
Hallenbeck JM, Frerichs KU. Hallenbeck JM, et al. Arch Neurol. 1993 Jul;50(7):768-70. doi: 10.1001/archneur.1993.00540070080020. Arch Neurol. 1993. PMID: 8323483 Review. No abstract available. - [Interleukin-1 and cancer].
WU X, XU K. WU X, et al. Zhongguo Fei Ai Za Zhi. 2010 Dec;13(12):1145-8. doi: 10.3779/j.issn.1009-3419.2010.12.12. Zhongguo Fei Ai Za Zhi. 2010. PMID: 21159252 Free PMC article. Review. Chinese. No abstract available.
Cited by
- Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.
van Baal JOAM, van Noorden CJF, Nieuwland R, Van de Vijver KK, Sturk A, van Driel WJ, Kenter GG, Lok CAR. van Baal JOAM, et al. J Histochem Cytochem. 2018 Feb;66(2):67-83. doi: 10.1369/0022155417742897. Epub 2017 Nov 22. J Histochem Cytochem. 2018. PMID: 29164988 Free PMC article. Review. - Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring.
Masoumi-Moghaddam S, Amini A, Wei AQ, Robertson G, Morris DL. Masoumi-Moghaddam S, et al. J Ovarian Res. 2015 Aug 19;8:58. doi: 10.1186/s13048-015-0183-x. J Ovarian Res. 2015. PMID: 26282935 Free PMC article. - The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.
Haria D, Trinh BQ, Ko SY, Barengo N, Liu J, Naora H. Haria D, et al. Am J Pathol. 2015 Aug;185(8):2298-308. doi: 10.1016/j.ajpath.2015.04.004. Epub 2015 Jun 9. Am J Pathol. 2015. PMID: 26067154 Free PMC article. - Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours.
Mielczarek-Palacz A, Kondera-Anasz Z, Sikora J. Mielczarek-Palacz A, et al. Arch Med Sci. 2012 Nov 9;8(5):848-53. doi: 10.5114/aoms.2012.31384. Epub 2012 Oct 30. Arch Med Sci. 2012. PMID: 23185194 Free PMC article. - Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions.
Ward BC, Kavalukas S, Brugnano J, Barbul A, Panitch A. Ward BC, et al. J Surg Res. 2011 Jul;169(1):e27-36. doi: 10.1016/j.jss.2011.01.043. Epub 2011 Feb 23. J Surg Res. 2011. PMID: 21492875 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical